Prostate cancer originates in the male prostate gland and has become one of the most common types of cancer. It typically remains confined in this region, however it may spread to other locations throughout the body. Risk of prostate cancer increases with age, family history, obesity, and ethnicity as black males are the most likely to develop prostate cancer. Treatment for prostate cancer includes radiation therapy, hormone therapy, surgery, and chemotherapy. In stage I of prostate cancer, the cancer is localized to the prostate. It is typically found through needle biopsy, is located in 1/2 or less of the prostate, and cannot be felt during a rectal exam or found through imaging. PSA levels in this stage are lower than 10 and Gleason scores are below 6.
Stage A Prostate Cancer Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Stage A Prostate Cancer below!
For more information on how to use Laverne, please read the How to Guide.
We have 1077 products for the study of Stage A Prostate Cancer that can be applied to Western Blot, Immunocytochemistry/Immunofluorescence, Flow Cytometry, Immunohistochemistry from our catalog of antibodies and ELISA kits.